Rx 360 International Pharmaceutical Supply Chain Consortium
EIN: 452410498 · Philadelphia, PA · NTEE: J03
| Metric | Value |
|---|---|
| Total Revenue | $5.0M |
| Total Expenses | $3.5M |
| Net Assets | $2.5M |
Is Rx 360 International Pharmaceutical Supply Chain Consortium Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Rx 360 International Pharmaceutical Supply Chain Consortium
Rx 360 International Pharmaceutical Supply Chain Consortium (EIN: 452410498) is a nonprofit organization based in Philadelphia, PA, classified under NTEE code J03. The organization reported total revenue of $5.0M and total assets of $5.8M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Rx 360 International Pharmaceutical Supply Chain Consortium's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Rx 360 International Pharmaceutical Supply Chain Consortium is a mid-size nonprofit that has been operating for 14 years, with 14 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 15.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $4.2M |
| Total Expenses | $3.5M |
| Surplus / Deficit | +$673K |
| Total Assets | $3.7M |
| Total Liabilities | $1.1M |
| Net Assets | $2.5M |
| Operating Margin | 16.0% |
| Debt-to-Asset Ratio | 31.3% |
| Months of Reserves | 12.4 months |
Financial Health Grade: A
In 2023, Rx 360 International Pharmaceutical Supply Chain Consortium reported a surplus of $673K with revenue exceeding expenses, holds 12.4 months of operating reserves (strong position), has a debt-to-asset ratio of 31.3% (moderate leverage).
Financial Trends
Over 14 years of filings (2011–2023), Rx 360 International Pharmaceutical Supply Chain Consortium's revenue has grown at a compound annual growth rate (CAGR) of 15.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +17.4% | +18.5% | +22.0% |
| 2022 | +21.9% | +45.5% | +40.4% |
| 2021 | +63.2% | +32.1% | +122.3% |
| 2020 | +22.9% | +4.4% | +35.6% |
| 2019 | -23.8% | -19.2% | -13.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2012 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Rx 360 International Pharmaceutical Supply Chain Consortium has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Rx 360 International Pharmaceutical Supply Chain Consortium with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $673K, with revenue exceeding expenses.
- Debt-to-asset ratio: 31.3%.
Frequently Asked Questions about Rx 360 International Pharmaceutical Supply Chain Consortium
Is Rx 360 International Pharmaceutical Supply Chain Consortium a legitimate charity?
Based on AI analysis of IRS 990 filings, Rx 360 International Pharmaceutical Supply Chain Consortium (EIN: 452410498) insufficient data. 0 red flags identified, 0 strengths noted.
How does Rx 360 International Pharmaceutical Supply Chain Consortium spend its money?
Detailed spending breakdown data is not yet available for Rx 360 International Pharmaceutical Supply Chain Consortium. Check back for updated IRS 990 analysis.
Are donations to Rx 360 International Pharmaceutical Supply Chain Consortium tax-deductible?
Rx 360 International Pharmaceutical Supply Chain Consortium is registered as a tax-exempt nonprofit (EIN: 452410498). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Rx 360 International Pharmaceutical Supply Chain Consortium located?
Rx 360 International Pharmaceutical Supply Chain Consortium is headquartered in Philadelphia, Pennsylvania and files with the IRS under EIN 452410498. It is classified under NTEE code J03.
How many years of IRS 990 filings does Rx 360 International Pharmaceutical Supply Chain Consortium have?
Rx 360 International Pharmaceutical Supply Chain Consortium has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $5.0M in total revenue.
Filing History
IRS 990 filing history for Rx 360 International Pharmaceutical Supply Chain Consortium showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2011–2023), Rx 360 International Pharmaceutical Supply Chain Consortium's revenue has grown by 444.4%, moving from $774K to $4.2M. Total assets increased by 1256.8% over the same period, from $270K to $3.7M. Total functional expenses rose by 357.5%, from $774K to $3.5M. In its most recent filing year (2023), Rx 360 International Pharmaceutical Supply Chain Consortium reported a surplus of $673K, with revenue exceeding expenses. The organization holds $1.1M in liabilities against $3.7M in assets (debt-to-asset ratio: 31.3%), resulting in net assets of $2.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $4.2M | $3.5M | $3.7M | $1.1M | — | — |
| 2022 | $3.6M | $3.0M | $3.0M | $1.2M | — | View 990 |
| 2021 | $2.9M | $2.1M | $2.1M | $896K | — | View 990 |
| 2020 | $1.8M | $1.6M | $961K | $610K | — | — |
| 2019 | $1.5M | $1.5M | $709K | $615K | — | — |
| 2018 | $1.9M | $1.8M | $815K | $700K | — | View 990 |
| 2017 | $1.6M | $1.5M | $1.4M | $1.2M | — | View 990 |
| 2016 | $602K | $721K | $937K | $727K | — | View 990 |
| 2016 | $1.8M | $1.5M | $585K | $255K | — | — |
| 2015 | $1.7M | $1.6M | $689K | $444K | — | View 990 |
| 2014 | $1.6M | $1.5M | $422K | $303K | — | View 990 |
| 2013 | $1.8M | $1.8M | $483K | $483K | — | View 990 |
| 2012 | $1.3M | $1.3M | $412K | $412K | — | View 990 |
| 2011 | $774K | $774K | $270K | $270K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $4.2M, expenses of $3.5M, and assets of $3.7M (revenue +17.4% year-over-year).
- 2022: Revenue of $3.6M, expenses of $3.0M, and assets of $3.0M (revenue +21.9% year-over-year).
- 2021: Revenue of $2.9M, expenses of $2.1M, and assets of $2.1M (revenue +63.2% year-over-year).
- 2020: Revenue of $1.8M, expenses of $1.6M, and assets of $961K (revenue +22.9% year-over-year).
- 2019: Revenue of $1.5M, expenses of $1.5M, and assets of $709K (revenue -23.8% year-over-year).
- 2018: Revenue of $1.9M, expenses of $1.8M, and assets of $815K (revenue +17.2% year-over-year).
- 2017: Revenue of $1.6M, expenses of $1.5M, and assets of $1.4M (revenue +173.0% year-over-year).
- 2016: Revenue of $602K, expenses of $721K, and assets of $937K (revenue -66.1% year-over-year).
- 2016: Revenue of $1.8M, expenses of $1.5M, and assets of $585K (revenue +3.8% year-over-year).
- 2015: Revenue of $1.7M, expenses of $1.6M, and assets of $689K (revenue +8.6% year-over-year).
- 2014: Revenue of $1.6M, expenses of $1.5M, and assets of $422K (revenue -10.2% year-over-year).
- 2013: Revenue of $1.8M, expenses of $1.8M, and assets of $483K (revenue +33.3% year-over-year).
- 2012: Revenue of $1.3M, expenses of $1.3M, and assets of $412K (revenue +70.1% year-over-year).
- 2011: Revenue of $774K, expenses of $774K, and assets of $270K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Rx 360 International Pharmaceutical Supply Chain Consortium:
Data Sources and Methodology
This transparency report for Rx 360 International Pharmaceutical Supply Chain Consortium is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.